— Know what they know.
Not Investment Advice

GH NASDAQ

Guardant Health, Inc.
1W: +9.5% 1M: +0.4% 3M: +23.6% YTD: +75.0% 1Y: +146.8% 3Y: +585.1% 5Y: +79.1%
$178.06
+4.81 (+2.78%)
After Hours: $174.97 (-3.09, -1.73%)
Weekly Expected Move ±7.0%
$146 $157 $169 $181 $193
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 61 · $23.9B mcap · 129M float · 1.79% daily turnover · Short 48% of daily vol
Credit Risk of going bust: lower than 59% of companies Debt: 6.8% of company value Bonds: $181.2M held by 51 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.31 (down 99.3%), Guardant Health, Inc. would be worth roughly what it owes.
Total debt $1.70B against a stock market value of $23.25B.
Distance to default 6.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $751.5M (short-term plus half of long-term), stock volatility 56.8%; Altman Z'' -3.67. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -88.3%
Cost Advantage
39
Intangibles
55
Switching Cost
45
Network Effect
82
Scale
51
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GH shows a Weak competitive edge (52.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -88.3% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$180
Low
$202
Avg Target
$225
High
Based on 17 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 30Hold: 0Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$202.12
Analysts17
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-27 BTIG Mark Massaro $195 $210 +15 +21.2% $173.25
2026-10-12 Morgan Stanley Kallum Titchmarsh $185 $200 +15 +22.7% $162.99
2026-10-07 Barclays Luke Sergott $200 $220 +20 +28.9% $170.69
2026-10-01 Guggenheim — $190 $200 +10 +12.8% $177.25
2026-09-10 Bernstein Eve Burstein $200 $210 +10 +30.2% $161.25
2026-09-09 UBS — $150 $225 +75 +39.8% $160.98
2026-09-08 Redburn Partners — Initiated $203 — +25.8% $161.41
2026-08-04 Morgan Stanley — $175 $185 +10 +15.4% $160.36
2026-08-04 Stephens — $99 $195 +96 +22.8% $158.83
2026-08-04 Piper Sandler — $127 $193 +66 +21.5% $158.83
2026-07-31 RBC Capital Dan Leonard $210 $200 -10 +23.6% $161.87
2026-07-31 RBC Capital — $185 $210 +25 +30.4% $161.00
2026-07-31 Stifel Nicolaus Daniel Arias $130 $180 +50 +18.1% $152.35
2026-07-31 Goldman Sachs — $165 $210 +45 +37.8% $152.35
2026-07-31 Mizuho Securities Anthony Petrone $175 $200 +25 +31.3% $152.35
2026-07-31 BTIG Mark Massaro $190 $195 +5 +28.0% $152.35
2026-07-31 Barclays — $115 $200 +85 +31.3% $152.35
2026-07-16 Guggenheim — $160 $190 +30 +16.6% $162.96
2026-07-14 Canaccord Genuity Kyle Mikson $135 $205 +70 +29.4% $158.40
2026-07-09 Morgan Stanley — $130 $175 +45 +12.1% $156.17
2026-07-06 Evercore ISI Vijay Kumar $160 $200 +40 +18.0% $169.45
2026-07-02 Bernstein Eve Burstein Initiated $200 — +17.1% $170.77
2026-07-01 BTIG — $160 $190 +30 +11.6% $170.19
2026-06-29 Guggenheim — $135 $160 +25 +7.2% $149.22
2026-06-24 UBS — $175 $150 -25 +14.7% $130.83
2026-06-11 RBC Capital Dan Leonard Initiated $185 — +41.3% $130.90
2026-06-08 Mizuho Securities — $135 $175 +40 +39.3% $125.61
2026-06-05 Goldman Sachs Evie Koslosky $45 $165 +120 +24.0% $133.06
2026-06-02 Evercore ISI — $110 $160 +50 +23.9% $129.14
2026-05-27 BTIG — $155 $160 +5 +25.6% $127.41
2026-05-26 BTIG Mark Massaro $145 $155 +10 +30.3% $118.95
2026-05-21 Piper Sandler — $135 $127 -8 +6.4% $119.33
2026-05-12 Piper Sandler David Westenberg $130 $135 +5 +39.6% $96.71
2026-04-14 Barclays Luke Sergott $130 $115 -15 +39.9% $82.21
2026-02-24 Piper Sandler — $90 $130 +40 +37.7% $94.42
2026-02-23 Raymond James — Initiated $129 — +32.3% $97.49
2026-02-20 Evercore ISI — $105 $110 +5 +3.0% $106.84
2026-02-20 BTIG — $140 $145 +5 +36.3% $106.38
2026-02-20 Stifel Nicolaus — $120 $130 +10 +22.2% $106.38
2026-02-20 Canaccord Genuity — $125 $135 +10 +26.9% $106.38
2026-02-20 Barclays — $120 $130 +10 +22.2% $106.38
2026-02-17 Robert W. Baird Catherine Schulte Initiated $120 — +14.4% $104.85
2026-01-30 UBS — $110 $175 +65 +57.7% $111.00
2026-01-26 Guggenheim — $115 $135 +20 +16.7% $115.69
2026-01-09 Stifel Nicolaus — $70 $120 +50 +10.4% $108.74
2026-01-09 Mizuho Securities — $120 $135 +15 +24.1% $108.74
2026-01-05 Guggenheim Subbu Nambi $36 $115 +79 +16.2% $99.00
2026-01-05 Evercore ISI Vijay Kumar Initiated $105 — +3.2% $101.74
2025-12-22 Canaccord Genuity — $100 $125 +25 +25.3% $99.74
2025-12-17 Mizuho Securities — $100 $120 +20 +20.0% $100.00

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GH receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-06-29 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 42 Grade D
Profitability
20
Balance Sheet
0
Earnings Quality
36
Growth
63
Value
32
Momentum
59
Safety
90
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GH scores highest in Safety (90/100) and lowest in Balance Sheet (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.69
Safe Zone
Piotroski F-Score
6/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
-2.85
Unlikely Manipulator
Ohlson O-Score
-4.73
Bankruptcy prob: 0.9%
Low Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.38x
Accruals: -17.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GH scores 3.69, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GH scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GH's score of -2.85 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GH's implied 0.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GH receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-51.14x
PEG
11.59x
P/S
20.25x
P/B
-105.78x
P/FCF
-86.74x
P/OCF
—
EV/EBITDA
-49.75x
EV/Revenue
17.29x
EV/EBIT
-45.50x
EV/FCF
-89.56x
Earnings Yield
-2.29%
FCF Yield
-1.15%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. GH currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.998
NI / EBT
×
Interest Burden
1.011
EBT / EBIT
×
EBIT Margin
-0.380
EBIT / Rev
×
Asset Turnover
0.729
Rev / Assets
×
Equity Multiplier
-6.141
Assets / Equity
=
ROE
171.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GH's ROE of 171.6% is driven by Asset Turnover (0.729), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$178.06
Median 1Y
$159.52
5th Pctile
$52.92
95th Pctile
$481.54
Ann. Volatility
64.3%
Analyst Target
$202.12
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Ines Dahne-Steuber Operating
ief Operating Officer
$307,101 $2,611,538 $5,836,716
Darya Chudova Technology
nology Officer
$424,462 $2,222,397 $4,755,541
Michael Bell Financial
ancial Officer
$482,000 $1,851,413 $4,123,993
Christopher Freeman Commercial
ercial Officer
$490,385 $1,621,395 $3,523,052
Craig Eagle Medical
edical Officer
$497,462 $1,565,107 $3,485,356
AmirAli Talasaz Co-Chief
Executive Officer
$1 $— $26,415
Helmy Eltoukhy Co-Chief
and Co-Chief Executive Officer
$1 $— $11,591

CEO Pay Ratio

0:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $26,415
Avg Employee Cost (SGA/emp): $283,563
Employees: 2,490

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,490
+24.6% YoY
Revenue / Employee
$394,386
Rev: $982,021,000
Profit / Employee
$-167,180
NI: $-416,277,000
SGA / Employee
$283,563
Avg labor cost proxy
R&D / Employee
$146,261
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -45.3% -41.7% -60.8% -99.6% -1.4% -1.9% -2.7% -1.7% -2.2% -4.4% -38.8% -3.4% -6.1% -45.8% 4.6% 2.7% 1.9% 3.5% 2.0% 1.7% 1.72%
ROA -23.4% -18.1% -18.7% -26.6% -30.8% -34.3% -36.5% -27.5% -24.7% -28.2% -28.7% -28.5% -30.7% -26.7% -27.3% -28.1% -28.3% -23.8% -26.6% -28.0% -27.95%
ROIC -54.8% -29.9% -35.5% -43.1% -67.4% -1.0% -1.1% -1.0% -93.9% -1.3% -1.5% -1.3% -1.5% -98.3% -1.0% -91.1% -89.2% -90.5% -84.0% -88.3% -88.31%
ROCE -18.8% -19.0% -20.9% -31.4% -38.2% -45.9% -50.5% -30.8% -27.2% -30.1% -30.8% -34.6% -38.0% -34.3% -36.9% -37.5% -37.9% -24.2% -26.5% -28.6% -28.58%
Gross Margin 67.5% 69.1% 66.7% 66.3% 65.5% 62.9% 58.8% 60.7% 59.7% 1.5% 61.2% 59.1% 61.1% 61.6% 63.3% 65.0% 64.7% 64.6% 65.2% 65.4% 65.39%
Operating Margin -1.1% -90.8% -1.3% -1.2% -1.2% -1.2% -1.0% -87.2% -79.4% -1.3% -59.2% -56.8% -61.3% -62.4% -54.6% -45.9% -37.3% -43.0% -40.2% -38.5% -38.55%
Net Margin -1.1% -84.1% -1.3% -2.1% -1.4% -1.1% -1.0% -53.1% -60.2% -1.2% -68.2% -57.9% -56.3% -55.0% -46.8% -43.0% -35.0% -45.7% -37.2% -35.9% -35.87%
EBITDA Margin -1.1% -60.6% -1.2% -2.0% -1.3% -1.0% -95.0% -44.5% -51.7% -1.1% -61.3% -51.4% -50.4% -49.1% -41.2% -38.3% -31.0% -42.3% -33.5% -32.6% -32.55%
FCF Margin -72.4% -76.0% -79.1% -89.0% -90.0% -86.1% -86.6% -75.1% -67.8% -61.3% -49.8% -46.5% -39.6% -37.2% -39.4% -32.8% -29.1% -22.5% -20.8% -19.3% -19.31%
OCF Margin -55.6% -55.9% -56.6% -66.3% -68.6% -68.8% -73.7% -66.1% -62.9% -57.6% -46.5% -43.6% -36.7% -32.5% -35.2% -28.8% -24.7% -17.6% -16.2% -14.6% -14.61%
ROA 3Y Avg snapshot only -28.42%
ROIC Economic snapshot only -25.61%
Cash ROA snapshot only -9.04%
Cash ROIC snapshot only -41.10%
CROIC snapshot only -54.30%
NOPAT Margin snapshot only -31.40%
Pretax Margin snapshot only -38.41%
R&D / Revenue snapshot only 31.76%
SGA / Revenue snapshot only 73.00%
SBC / Revenue snapshot only 12.52%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -31.04 -25.07 -16.09 -7.47 -9.09 -4.26 -3.62 -7.66 -8.07 -6.69 -5.45 -7.21 -5.51 -8.66 -12.67 -15.61 -19.63 -31.57 -27.99 -43.70 -51.144
P/S Ratio 36.87 27.22 17.25 10.09 12.78 6.20 4.99 7.64 6.51 5.68 4.16 5.49 4.08 5.12 6.82 7.79 8.67 13.38 11.23 16.75 20.246
P/B Ratio 17.87 15.77 12.66 12.90 33.02 46.33 -54.01 13.31 15.29 20.20 36.77 -2192.36 -46.97 -27.07 -21.04 -21.14 -22.09 -132.33 -66.97 -88.91 -105.777
P/FCF -50.93 -35.81 -21.80 -11.33 -14.20 -7.21 -5.76 -10.17 -9.60 -9.28 -8.35 -11.82 -10.29 -13.75 -17.31 -23.77 -29.86 -59.52 -53.93 -86.74 -86.743
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -33.24 -29.50 -19.17 -9.25 -10.73 -5.12 -4.56 -8.70 -9.57 -7.83 -6.59 -8.65 -6.77 -10.96 -15.88 -19.45 -24.22 -36.43 -32.55 -49.75 -49.754
EV/Revenue 36.50 28.40 18.31 11.37 13.75 7.00 5.88 7.90 6.89 6.01 4.52 5.97 4.57 5.79 7.60 8.64 9.50 13.87 11.78 17.29 17.292
EV/EBIT -31.51 -27.79 -18.00 -8.76 -10.14 -4.83 -4.29 -8.00 -8.63 -7.12 -5.97 -7.88 -6.20 -9.89 -14.26 -17.49 -21.75 -32.93 -29.60 -45.50 -45.499
EV/FCF -50.42 -37.36 -23.14 -12.77 -15.27 -8.13 -6.79 -10.52 -10.16 -9.82 -9.08 -12.84 -11.53 -15.56 -19.30 -26.36 -32.70 -61.70 -56.61 -89.56 -89.560
Earnings Yield -3.2% -4.0% -6.2% -13.4% -11.0% -23.5% -27.6% -13.0% -12.4% -15.0% -18.4% -13.9% -18.2% -11.5% -7.9% -6.4% -5.1% -3.2% -3.6% -2.3% -2.29%
FCF Yield -2.0% -2.8% -4.6% -8.8% -7.0% -13.9% -17.4% -9.8% -10.4% -10.8% -12.0% -8.5% -9.7% -7.3% -5.8% -4.2% -3.3% -1.7% -1.9% -1.2% -1.15%
PEG Ratio snapshot only 11.594
EV/Gross Profit snapshot only 26.599
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 15.58 5.72 4.87 6.18 6.46 6.17 5.41 6.96 5.94 6.54 5.95 6.40 6.22 4.68 4.11 3.71 3.50 4.84 4.68 4.03 4.026
Quick Ratio 15.33 5.57 4.71 5.83 6.10 5.90 5.18 6.65 5.60 6.24 5.66 6.07 5.85 4.36 3.76 3.35 3.12 4.56 4.39 3.71 3.715
Debt/Equity 1.92 2.13 2.58 4.32 8.24 22.75 -30.67 4.65 5.95 8.53 19.73 -831.44 -22.29 -9.57 -5.21 -4.37 -3.74 -16.94 -9.41 -7.61 -7.614
Net Debt/Equity -0.18 0.68 0.78 1.64 2.49 5.95 — 0.47 0.89 1.17 3.20 — — — — — — — — — —
Debt/Assets 0.61 0.62 0.65 0.74 0.81 0.85 0.90 0.74 0.76 0.76 0.79 0.83 0.87 0.90 0.97 1.00 1.04 0.84 0.89 0.89 0.887
Debt/EBITDA -3.60 -3.82 -3.69 -2.74 -2.49 -2.23 -2.20 -2.94 -3.52 -3.12 -3.25 -3.02 -2.87 -3.43 -3.52 -3.62 -3.75 -4.50 -4.36 -4.13 -4.127
Net Debt/EBITDA 0.34 -1.23 -1.11 -1.04 -0.75 -0.58 -0.69 -0.30 -0.53 -0.43 -0.53 -0.69 -0.73 -1.27 -1.64 -1.91 -2.11 -1.29 -1.54 -1.57 -1.565
Interest Coverage -59.71 -148.19 -154.52 -205.51 -226.65 -252.57 -256.47 -195.65 -166.06 -184.71 -177.38 -189.10 -197.52 -167.57 -151.32 -133.66 -117.27 -106.14 -96.55 -93.37 -93.367
Equity Multiplier 3.14 3.42 4.00 5.81 10.21 26.75 -33.93 6.29 7.87 11.26 24.96 -997.73 -25.60 -10.64 -5.36 -4.36 -3.60 -20.28 -10.58 -8.58 -8.580
Cash Ratio snapshot only 3.108
Debt Service Coverage snapshot only -85.381
Cash to Debt snapshot only 0.621
FCF to Debt snapshot only -0.135
Defensive Interval snapshot only 352.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.20 0.17 0.17 0.20 0.22 0.24 0.26 0.28 0.31 0.33 0.38 0.37 0.42 0.45 0.51 0.56 0.64 0.56 0.66 0.73 0.729
Inventory Turnover 4.49 4.60 3.85 3.08 3.25 3.80 4.27 3.23 3.02 1.47 1.75 1.79 1.76 4.36 4.27 4.08 4.02 4.45 4.71 4.37 4.368
Receivables Turnover 7.09 4.95 5.91 5.48 5.86 4.61 5.62 5.61 6.12 6.23 7.03 6.89 7.81 7.75 7.91 7.30 8.85 8.03 8.69 8.74 8.741
Payables Turnover 6.94 5.36 4.63 4.56 5.04 2.91 3.56 3.33 3.57 1.38 1.82 1.87 2.81 6.42 6.85 7.06 18.37 7.51 6.08 5.99 5.986
DSO 51 74 62 67 62 79 65 65 60 59 52 53 47 47 46 50 41 45 42 42 41.8 days
DIO 81 79 95 119 112 96 85 113 121 248 209 204 208 84 86 89 91 82 78 84 83.6 days
DPO 53 68 79 80 72 125 102 110 102 264 200 195 130 57 53 52 20 49 60 61 61.0 days
Cash Conversion Cycle 80 85 78 105 102 50 48 68 78 43 61 61 125 74 78 88 112 79 59 64 64.3 days
Fixed Asset Turnover snapshot only 3.906
Operating Cycle snapshot only 125.3 days
Cash Velocity snapshot only 1.123
Capital Intensity snapshot only 1.616
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 26.7% 30.3% 31.3% 26.1% 25.3% 20.3% 23.3% 25.0% 24.4% 25.5% 25.2% 26.2% 29.2% 31.0% 28.2% 28.7% 30.4% 32.9% 39.6% 42.7% 42.74%
Net Income -1.2% -59.8% -24.9% -45.5% -48.2% -61.4% -58.6% 7.8% 28.6% 26.8% 30.7% 3.4% -18.5% 9.0% 9.6% 15.7% 22.2% 4.6% -4.0% -9.6% -9.57%
EPS -1.2% -57.2% -23.8% -44.3% -47.0% -60.1% -57.3% 13.5% 38.0% 36.6% 41.5% 14.2% -13.4% 12.8% 11.2% 16.8% 23.6% 8.2% 1.9% -3.0% -2.97%
FCF -93.1% -79.8% -1.2% -89.7% -55.8% -36.2% -34.9% -5.5% 6.3% 10.7% 28.0% 21.9% 24.5% 20.4% -1.4% 9.2% 4.4% 19.7% 26.3% 15.9% 15.93%
EBITDA -1.4% -62.3% -26.1% -46.1% -46.2% -71.0% -66.5% 7.7% 30.1% 29.5% 33.4% 4.1% -21.0% 10.0% 10.5% 17.1% 24.2% 4.1% -5.5% -11.6% -11.63%
Op. Income -1.1% -61.2% -30.1% -23.8% -22.9% -32.5% -30.2% -18.6% -3.4% -3.7% 4.5% 6.1% -0.4% 21.4% 14.2% 9.9% 14.1% 1.4% 1.6% -2.1% -2.07%
OCF Growth snapshot only 27.52%
Asset Growth snapshot only 43.57%
Debt Growth snapshot only 27.20%
Shares Change snapshot only 6.41%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — 1.2% 77.8% 48.9% 32.7% 28.0% 25.3% 25.6% 25.5% 25.3% 26.6% 25.8% 26.3% 25.5% 25.6% 26.6% 28.0% 29.8% 30.9% 32.4% 32.36%
Revenue 5Y — — — — — — — — — 76.6% 54.1% 39.1% 30.3% 28.1% 25.8% 26.3% 27.2% 27.9% 29.4% 29.6% 29.60%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — 1.4% 84.7% 51.5% 33.3% 26.8% 22.1% 21.9% 20.5% 35.3% 37.1% 35.0% 35.4% 21.5% 21.5% 23.7% 25.9% 29.2% 32.0% 34.6% 34.57%
Gross Profit 5Y — — — — — — — — — 91.0% 64.6% 46.2% 35.8% 25.6% 23.2% 24.5% 25.4% 26.7% 28.9% 29.0% 28.99%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — 55.4% 54.3% 25.4% 21.5% 18.7% 16.8% 12.9% 12.5% -7.7% -10.1% -11.1% -11.6% -12.3% -14.2% -10.4% -9.1% 7.7% 8.2% 1.3% 1.29%
Assets 5Y — — — — — — — — — 24.9% 24.1% 11.4% 10.2% 9.1% 7.2% 0.8% 0.2% -2.4% -4.0% -3.6% -3.56%
Equity 3Y — 10.1% 4.4% -26.9% -41.1% -57.8% — -36.0% -40.7% -50.4% -56.8% — — — — — — — — — —
Book Value 3Y — 3.4% -1.3% -30.1% -42.9% -59.0% — -38.6% -43.9% -53.1% -59.4% — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 0.95 0.94 0.98 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 0.98 0.96 0.96 0.96 0.95 0.94 0.93 0.91 0.912
Earnings Stability 0.96 0.96 0.91 0.95 0.98 0.96 0.95 0.88 0.72 0.84 0.78 0.78 0.69 0.54 0.42 0.37 0.21 0.09 0.02 0.00 0.002
Margin Stability 0.98 0.92 0.95 0.98 0.98 0.98 0.97 0.96 0.95 0.85 0.86 0.88 0.89 0.86 0.87 0.88 0.88 0.86 0.86 0.88 0.877
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 1.00 1.00 1.00 0.50 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.90 0.82 0.81 0.50 0.50 0.97 0.89 0.89 0.88 0.99 0.93 0.96 0.96 0.94 0.91 0.98 0.98 0.96 0.962
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.44 -0.48 -0.54 -1.43 -3.26 -10.46 — -0.63 0.21 2.73 — — — — — — — — — — —
Gross Margin Trend -0.01 -0.00 0.01 0.00 -0.00 -0.02 -0.04 -0.05 -0.06 0.19 0.19 0.18 0.17 -0.14 -0.12 -0.09 -0.07 -0.09 -0.08 -0.08 -0.075
FCF Margin Trend -0.32 -0.33 -0.34 -0.36 -0.30 -0.21 -0.23 -0.01 0.13 0.20 0.33 0.36 0.39 0.36 0.29 0.28 0.25 0.27 0.24 0.20 0.203
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.47 0.52 0.53 0.49 0.49 0.47 0.53 0.66 0.78 0.68 0.61 0.57 0.50 0.55 0.65 0.58 0.56 0.41 0.40 0.38 0.381
FCF/OCF 1.30 1.36 1.40 1.34 1.31 1.25 1.18 1.14 1.08 1.06 1.07 1.07 1.08 1.15 1.12 1.14 1.18 1.28 1.28 1.32 1.321
FCF/Net Income snapshot only 0.504
CapEx/Revenue 16.8% 20.1% 22.5% 22.7% 21.4% 17.2% 12.9% 9.0% 4.9% 3.6% 3.3% 2.9% 2.9% 4.7% 4.2% 4.0% 4.4% 4.9% 4.6% 4.7% 4.69%
CapEx/Depreciation snapshot only 1.444
Accruals Ratio -0.12 -0.09 -0.09 -0.14 -0.16 -0.18 -0.17 -0.09 -0.05 -0.09 -0.11 -0.12 -0.15 -0.12 -0.09 -0.12 -0.12 -0.14 -0.16 -0.17 -0.173
Sloan Accruals snapshot only 0.211
Cash Flow Adequacy snapshot only -3.113
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.9% 0.7% 0.6% 0.3% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.8% -3.6% -2.6% -3.2% 0.0% 0.9% 0.6% 0.4% -2.4% -3.0% -2.0% -1.95%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.8% -3.6% -2.6% -3.2% 0.0% 0.9% 0.6% 0.4% -2.4% -3.0% -2.0% -1.95%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.01 1.06 1.05 1.04 1.03 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.998
Interest Burden (EBT/EBIT) 1.02 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.011
EBIT Margin -1.16 -1.02 -1.02 -1.30 -1.36 -1.45 -1.37 -0.99 -0.80 -0.84 -0.76 -0.76 -0.74 -0.59 -0.53 -0.49 -0.44 -0.42 -0.40 -0.38 -0.380
Asset Turnover 0.20 0.17 0.17 0.20 0.22 0.24 0.26 0.28 0.31 0.33 0.38 0.37 0.42 0.45 0.51 0.56 0.64 0.56 0.66 0.73 0.729
Equity Multiplier 1.94 2.30 3.24 3.74 4.48 5.41 7.45 6.04 8.86 15.52 135.51 11.85 19.83 171.88 -16.71 -9.58 -6.79 -14.64 -7.55 -6.14 -6.141
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-4.03 $-3.99 $-4.12 $-5.40 $-5.92 $-6.39 $-6.48 $-4.67 $-3.67 $-4.05 $-3.79 $-4.01 $-4.16 $-3.53 $-3.36 $-3.33 $-3.18 $-3.24 $-3.30 $-3.43 $-3.43
Book Value/Share $6.99 $6.34 $5.23 $3.13 $1.63 $0.59 $-0.43 $2.69 $1.94 $1.34 $0.56 $-0.01 $-0.49 $-1.13 $-2.02 $-2.46 $-2.83 $-0.77 $-1.38 $-1.69 $-1.69
Tangible Book/Share $6.82 $6.17 $5.07 $2.97 $1.48 $0.44 $-0.57 $2.56 $1.83 $1.24 $0.47 $-0.10 $-0.57 $-1.21 $-2.10 $-2.54 $-2.90 $-1.57 $-2.16 $-2.46 $-2.46
Revenue/Share $3.39 $3.67 $3.84 $4.00 $4.21 $4.39 $4.70 $4.69 $4.55 $4.76 $4.96 $5.26 $5.63 $5.97 $6.25 $6.68 $7.20 $7.63 $8.23 $8.96 $8.96
FCF/Share $-2.45 $-2.79 $-3.04 $-3.56 $-3.79 $-3.77 $-4.07 $-3.52 $-3.09 $-2.92 $-2.47 $-2.44 $-2.23 $-2.22 $-2.46 $-2.19 $-2.09 $-1.72 $-1.71 $-1.73 $-1.82
OCF/Share $-1.89 $-2.06 $-2.17 $-2.65 $-2.89 $-3.02 $-3.46 $-3.10 $-2.86 $-2.74 $-2.31 $-2.29 $-2.06 $-1.94 $-2.20 $-1.92 $-1.78 $-1.34 $-1.34 $-1.31 $-1.40
Cash/Share $14.65 $9.17 $9.45 $8.37 $9.37 $9.86 $9.13 $11.26 $9.81 $9.86 $9.28 $8.45 $8.12 $6.79 $5.64 $5.07 $4.63 $9.34 $8.40 $7.98 $7.98
EBITDA/Share $-3.72 $-3.54 $-3.67 $-4.92 $-5.40 $-6.00 $-6.06 $-4.26 $-3.28 $-3.66 $-3.40 $-3.63 $-3.79 $-3.15 $-2.99 $-2.97 $-2.83 $-2.91 $-2.98 $-3.11 $-3.11
Debt/Share $13.40 $13.51 $13.52 $13.49 $13.43 $13.36 $13.31 $12.51 $11.54 $11.42 $11.07 $10.95 $10.89 $10.80 $10.55 $10.75 $10.59 $13.08 $12.98 $12.85 $12.85
Net Debt/Share $-1.25 $4.34 $4.08 $5.13 $4.06 $3.49 $4.18 $1.26 $1.73 $1.56 $1.79 $2.50 $2.77 $4.01 $4.91 $5.68 $5.96 $3.74 $4.58 $4.87 $4.87
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.692
Altman Z-Prime snapshot only 6.182
Piotroski F-Score 2 3 3 2 2 3 3 5 4 6 6 2 4 3 3 4 4 6 6 6 6
Beneish M-Score -1.63 -1.52 5.55 -0.91 -3.11 -3.89 -3.72 -3.15 -2.72 -2.92 -2.77 -3.18 -3.54 -2.03 -2.48 -1.54 -1.46 -2.64 -2.72 -2.85 -2.846
Ohlson O-Score snapshot only -4.735
Net-Net WC snapshot only $-5.83
EVA snapshot only $-413574680.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B-
Credit Score 53.90 47.82 40.87 28.01 27.43 23.47 20.00 28.60 26.84 22.72 23.27 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 50
Sector Credit Rank snapshot only 48

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms